Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China · Delayed Price · Currency is CNY 14.19
-0.07 (-0.49%)
May 6, 2026, 3:00 PM CST
Beijing Tiantan Biological Products Company Description
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationally.
Its products include human serum albumin; intravenous human immunoglobulin; rabies immunoglobulin; tetanus immunoglobulin; hepatitis B immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex concentrate; lyophilized intravenous hepatitis B immunoglobulin; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products.
The company was founded in 1966 and is headquartered in Beijing, China.
Beijing Tiantan Biological Products Co., Ltd.
| Country | China |
| Founded | 1966 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 5,205 |
| CEO | Yanlin He |
Contact Details
Address: No.B2 Shuangqiao Road Beijing, 100024 China | |
| Phone | 86 10 6543 4018 |
| Website | tiantanbio.com |
Stock Details
| Ticker Symbol | 600161 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000000WF9 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Yanlin He | Deputy GM and Director |
| Yana Liu | Deputy GM and Director |
| Hongqing Wang | Chief Financial Officer |
| Ding Yu | Deputy General Manager |